Supplier Research

ResistAid Enhances Immune System of Healthy Adults

October 5, 2010

New research demonstrates the ability of ResistAid, Lonza’s all-natural arabinogalactan-based immune ingredient, to increase the antibody response of healthy volunteers to the 23-valent pneumococcal (pneumonia) vaccine. The study was conducted in collaboration with Medicus Research LLC and published in the August issue of Nutrition Journal.
 
This randomized, double-blind, placebo-controlled, parallel group study demonstrate the ability of ResistAid to selectively enhance the antibody response to the pneumococcal vaccine, according to researchers.
 
The study showed vaccinated volunteers who received ResistAid for 30 days prior to the vaccine and up to Day 72 demonstrated significantly higher pneumococcal IgG levels in two antibodies subtypes (18C and 23F) at both Day 51 and at Day 72 compared to the placebo group. These same subtypes (18C and 23F) also demonstrated statistically significant change scores from baseline in the ResistAid group at Day 51 and at Day 72. For further information: www.lonza.com
blog comments powered by Disqus
  • Herbs & Botanicals Bounce Back

    Herbs & Botanicals Bounce Back

    Lisa Olivo, Associate Editor||July 1, 2016
    Industry rallies to cultivate quality with hopes of ensuring long-term market health.

  • Healthy Beverage Market Overflowing With Opportunities

    Healthy Beverage Market Overflowing With Opportunities

    Sean Moloughney, Editor||July 1, 2016
    Clean and simple formulas that incorporate vital nutrients will continue to gain market share.

  • Choosing The Right Analytical Lab

    Choosing The Right Analytical Lab

    Maged Sharaf, PhD, American Herbal Products Association ||July 1, 2016
    Here are some important questions to consider when determining which contract laboratory will meet your needs.